Structure of the catalytic domain of the colistin resistance enzyme MCR-1
Related Experiment Video
Updated: Mar 14, 2026

Production, Crystallization and Structure Determination of C. difficile PPEP-1 via Microseeding and Zinc-SAD
Published on: December 30, 2016
Vlatko Stojanoski1,2, Banumathi Sankaran3, B V Venkataram Prasad1
1Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX, 77030, USA.
Background:
Due to the paucity of novel antibiotics, colistin has become a last resort antibiotic for treating multidrug resistant bacteria. Colistin acts by binding the lipid A component of lipopolysaccharides and subsequently disrupting the bacterial membrane. The recently identified plasmid-encoded MCR-1 enzyme is the first transmissible colistin resistance determinant and is a cause for concern for the spread of this resistance trait. MCR-1 is a phosphoethanolamine transferase that catalyzes the addition of phosphoethanolamine to lipid A to decrease colistin affinity.
Results:
The structure of the catalytic domain of MCR-1 at 1.32 Å reveals the active site is similar to that of related phosphoethanolamine transferases.
Conclusions:
The putative nucleophile for catalysis, threonine 285, is phosphorylated in cMCR-1 and a zinc is present at a conserved site in addition to three zincs more peripherally located in the active site. As noted for catalytic domains of other phosphoethanolamine transferases, binding sites for the lipid A and phosphatidylethanolamine substrates are not apparent in the cMCR-1 structure, suggesting that they are present in the membrane domain.
Insights
The MCR-1 enzyme confers resistance to colistin, a last-resort antibiotic. Structural analysis reveals its active site is similar to other phosphoethanolamine transferases, with key residues phosphorylated and zinc ions present.
Area of Science:
- Biochemistry
- Structural Biology
- Microbiology
Background:
- Colistin is a critical antibiotic for treating multidrug-resistant bacteria due to a lack of novel alternatives.
- The plasmid-encoded MCR-1 enzyme is the first transferable colistin resistance gene, raising significant public health concerns.
- MCR-1 is a phosphoethanolamine transferase that modifies lipid A, reducing colistin's effectiveness.
Purpose of the Study:
- To elucidate the structural basis of colistin resistance conferred by the MCR-1 enzyme.
- To understand the catalytic mechanism of MCR-1 and its interaction with substrates.
Main Methods:
- X-ray crystallography was used to determine the structure of the catalytic domain of MCR-1.
- Structural comparisons were made with related phosphoethanolamine transferases.
Main Results:
- The high-resolution (1.32 Å) crystal structure of the MCR-1 catalytic domain was determined.
- The active site of MCR-1 shares similarities with other phosphoethanolamine transferases.
- Key catalytic residues, including Threonine 285, were found to be phosphorylated, and zinc ions were identified in the active site.
Conclusions:
- The structure reveals a phosphorylated nucleophile (Threonine 285) and conserved zinc ions within the MCR-1 active site.
- The absence of apparent binding sites for lipid A and phosphatidylethanolamine in the catalytic domain suggests these interactions occur within the membrane domain.
More Related Videos
Related Concept Videos
Multi-pass Transmembrane Proteins and β-barrels
α-Helix containing multi-pass transmembrane proteins
Multi-pass transmembrane proteins such as...
The Inner Mitochondrial Membrane
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Protein Folding
Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to...
Cytoskeletal Proteins in Bacteria

